Wall Street Analysts Predict an 111.38% Upside in Prime Medicine, Inc. (PRME): Here's What You Should Know

Prime Medicine, Inc. (PRME) closed the last trading session at $9.05, gaining 11% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $19.13 indicates an 111.4% upside potential.The average comprises eight short-term price targets ranging from a low of $10 to a high of $26, with a standard deviation of $5.67. While the lowest estimate indicates an increase of 10.5% from the current pri ...